Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.26
-0.18 (-2.80%)
Feb 11, 2026, 4:00 PM EST - Market closed
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $461.24 million as of February 12, 2026. Its market cap has increased by 325.55% in one year.
Market Cap
461.24M
Enterprise Value
322.22M
1-Year Change
325.55%
Ranking
Category
Stock Price
$6.26
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $461.24M, an increase of 175.66%. That is a compound annual growth rate of 25.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 474.50M | 39.26% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 458.56M |
| Tectonic Therapeutic | 456.12M |
| Kyverna Therapeutics | 453.04M |
| Invivyd | 448.36M |
| Vanda Pharmaceuticals | 447.36M |
| LENZ Therapeutics | 444.94M |
| DiaMedica Therapeutics | 439.34M |
| Ocugen | 436.09M |